Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | +8618964387627 |
| E-mail: | customer_service@efebio.com |
| QQ: | 3012643761 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Minalrestat | C19H11BrF2N2O4 | 129688-50-2 | Details |
| H-Ile-Lys-Val-Ala-Val-OH | C25H48N6O6 | 131167-89-0 | Details |
| Vinaxanthone | C28H16O14 | 133293-89-7 | Details |
| Sitagliptin fenilalanil hydrochloride | C25H24F6N6O2.ClH | 1339954-75-4 | Details |
| LY2881835 | C33H33NO3 | 1292290-38-0 | Details |
| PERK-IN-2 | C23H18F3N5O | 1337531-83-5 | Details |
| PKR-IN-C51 | C23H21N5 | 1314594-23-4 | Details |
| WY-47766 | C14H13N3O2S | 134217-27-9 | Details |
| Imifoplatin | C6H13N2O7P2Pt- | 1339960-28-9 | Details |
| Cavutilide | C22H26FN3O3 | 1276186-19-6 | Details |
| Ebaresdax hydrochloride | C12H15ClN2O3S | 1334385-87-3 | Details |
| Besipirdine hydrochloride | C16H17N3.ClH | 130953-69-4 | Details |
| Lesopitron HCl | C15H21ClN6.ClH | 132449-88-8 | Details |
| 3,5,6-trihydroxysitostane | C29H52O3 | 133697-68-4 | Details |
| Vamicamide | C18H23N3O | 132373-81-0 | Details |
| Cdc7-IN-7c | C15H17N5OS | 1330781-04-8 | Details |
| 5-A-RU hydrochloride | C9H17ClN4O6 | 134452-11-2 | Details |
| Compound 10w | C20H24F2N8O3 | 1336890-05-1 | Details |
| Nesvacumab | 1296818-77-3 | Details |
| Inebilizumab | 1299440-37-1 | Details |
| Fallaxsaponin A | C35H54O11 | 1287702-60-6 | Details |
| CYM50374 | C19H19NO3S | 1314212-81-1 | Details |
| (-)-Vorozole | C16H13ClN6 | 132042-69-4 | Details |
| ML089 | C13H8FNOS | 1306638-12-9 | Details |
| Endomorphin 1 acetate | C36H42N6O7 | 1276123-71-7 | Details |
| hGPR91 antagonist 3 | C23H18F4N4O2 | 1314796-31-0 | Details |
| (Rac)-Sabcomeline HCl | C10H15N3O.ClH | 133642-67-8 | Details |
| Enzaplatovir | C20H19N5O3 | 1323077-89-9 | Details |
| GSK854 | C18H19ClN6O4S2 | 1316059-00-3 | Details |
| EBOV-IN-1 | C34H43N3O5 | 1335113-30-8 | Details |
| Butyl chlorogenate | C20H26O9 | 132741-56-1 | Details |
| PFM39 | C10H9N3OS | 1310744-67-2 | Details |
| Concizumab | 1312299-39-0 | Details |
| Anifrolumab | 1326232-46-5 | Details |
| Iothalamate meglumine | C11H9I3N2O4.C7H17NO5 | 13087-53-1 | Details |
| SAR247799 | C21H16ClN3O5 | 1315311-14-8 | Details |
| Antifolate C2 | C19H21N5O6S | 1286279-90-0 | Details |
| (E/Z)-Zotiraciclib hydrochloride | C23H25ClN4O | 1321626-25-8 | Details |
| Maslimomab | 127757-92-0 | Details |
| Sitagliptin fenilalanil | C25H24F6N6O2 | 1339955-03-1 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| ABzOH | C12H10O2 | 1313028-09-9 | Details |
| Rucaparib camsylate | C29H34FN3O5S | 1327258-57-0 | Details |
| Quilseconazole | C22H14F7N5O2 | 1340593-70-5 | Details |
| Tubulin inhibitor 8 | C21H14N2O3 | 1309925-39-0 | Details |
| Orticumab | 1314241-10-5 | Details |
| Pinatuzumab vedotin | 1313706-14-7 | Details |
| HMBR | C11H9NO2S2 | 1287651-36-8 | Details |
| Dalvastatin | C24H31FO3 | 132100-55-1 | Details |
| Nemazoline Free Base | C10H11Cl2N3 | 130759-56-7 | Details |
| Safironil | C15H23N3O4 | 134377-69-8 | Details |
| Vorozole | C16H13ClN6 | 129731-10-8 | Details |
| Bocconoline | C22H21NO5 | 1322007-90-8 | Details |
| Lecimibide | C34H40F2N4OS | 130804-35-2 | Details |
| KAT modulator-1 | C20H36O2 | 1314006-43-3 | Details |
| Chloroprocaine | C13H19ClN2O2 | 133-16-4 | Details |
| Ampelopsin A | C28H22O7 | 130608-11-6 | Details |
| Syk-IN-3 | C24H28N4O3S | 1312534-69-2 | Details |
| Ozanezumab | 1310680-64-8 | Details |
| ALM301 | C25H25N3O3 | 1313439-71-2 | Details |
| TRC160334 | C14H15N3O5S | 1293289-69-6 | Details |
| HPPE | C21H20F3N5O3S | 1325721-55-8 | Details |
| Soretolide | C13H14N2O2 | 130403-08-6 | Details |
| Rilmakalim | C21H23NO5S | 132014-21-2 | Details |
| MK 0434 | C25H31NO2 | 134067-56-4 | Details |
| PERK-IN-6 | C23H22N6O | 1337532-14-5 | Details |
| PLH1215 | 1332084-64-6 | Details |
| Lampalizumab | 1278466-20-8 | Details |
| Simtuzumab | 1318075-13-6 | Details |
| Tildrakizumab | 1326244-10-3 | Details |
| Triumbelletin | C27H14O9 | 131559-54-1 | Details |
| Futuximab | 1310460-85-5 | Details |
| Parsatuzumab | 1312797-14-0 | Details |
| Vofatamab | 1312305-12-6 | Details |
| ML372 | C18H20N2O4S | 1331745-61-9 | Details |
| Opc 18750 | C20H22N2O4 | 128667-63-0 | Details |
| BW-1370U87 | C14H12O3S | 134476-36-1 | Details |
| LSD1-IN-30 | C15H14N2O3 | 1289575-45-6 | Details |
| Raxofelast | C15H18O5 | 128232-14-4 | Details |
| (Iso)-Samixogrel | 133276-52-5 | Details |
| 5-HT6/7 antagonist 1 | C22H20FN3O3 | 131999-28-5 | Details |
| Duligotuzumab | 1314238-96-4 | Details |
| Ligelizumab | 1322627-61-1 | Details |
| Seribantumab | 1334296-12-6 | Details |
| Tigulixostat | C16H14N4O2 | 1287766-55-5 | Details |
| Upacicalcet | C11H14ClN3O6S | 1333218-50-0 | Details |
| 20-HETE Intermediate 15 | C23H36O4 | 1286736-37-5 | Details |
| Aprikalim | C12H16N2OS2 | 132562-26-6 | Details |
| dCeMM4 | C14H15N3O3S2 | 1281683-44-0 | Details |
| Lesopitron | C15H21ClN6 | 132449-46-8 | Details |
| Tazomeline | C14H23N3S2 | 131987-54-7 | Details |
| Rocepafant | C26H23ClN6OS2 | 132579-32-9 | Details |
| PLpro/RBD-IN-1 | C13H10N4O | 1282451-83-5 | Details |
| Irtemazole | C18H16N4 | 129369-64-8 | Details |
| IMSs inhibitor S12 Perchlorate | C14H18ClN3O4 | 1334529-08-6 | Details |
| Palmatine hydroxide | C21H22NO4.HO | 131-04-4 | Details |
| MK-8325 | C43H53ClF2N8O6Si | 1334314-19-0 | Details |
| Modotuximab | 1310460-86-6 | Details |
| Abrilumab | 1342290-43-0 | Details |
| Demethylcantharidate disodium | C8H11NaO5 | 129-67-9 | Details |
| Product Total： Product Page： | ||||
| 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||